References

Words

Quantity

Frequency %

Masulis and Nahata (2009)

start-up

407

12.27%

Block et al. (2014)

start-up

333

10.04%

Greenberg (2013)

patent

234

7.06%

Wasserman (2017)

control

228

6.88%

Sievers et al. (2013)

financial

200

6.03%

Hsu (2007)

capital

197

5.94%

Kleinert and Volkmann (2019)

investors

180

5.43%

Davila et al. (2015)

valuation

176

5.31%

Zheng et al. (2010)

firm

169

5.10%

Berger and Kohn 2018

valuation

156

4.70%

Dhochak and Doliya, 2020

venture

147

4.43%

Yoo et al. (2012)

industry

128

3.86%

Ivanov and Xie (2010)

strategic

120

3.62%

Gavious and Schwartz (2011)

value

106

3.20%

Becker et al. (2016)

start-up

103

3.11%

Hornuf and Neuenkirch (2017)

funding

103

3.11%

Zhai and Carrick (2019)

firms

102

3.08%

Fujikawa (2014)

biotech

88

2.65%

Joglekar and Levesque (2009)

capital

88

2.65%

Audretsch and Link (2012)

entrepreneurial

51

1.54%

Total

3,316

100.00%